Steve Novak, CEO
Steve has had a varied career in both finance and technology. A Chartered Financial Analyst, Steve began his career in the investment management field, focused upon emerging growth companies, particularly in technology.
He has served on the Boards and occasionally as Chairman of numerous early stage companies, a few of which went on to become great successes in their fields, including Cybersource Corporation, an Internet payments processor handling nearly one out of three payments made on the Internet at the time of its sale to Visa in 2010, Cytomation, manufacturer of the world fastest flow cytometer which was acquired by Dako A/S, at the time the world leader in antibodies and reagents for the pathology lab, and Aperio Technologies, a pioneer in digital pathology which was sold to Leica Biosystems, a division of Danaher Corporation.
He also founded and served as President of Palladio Capital Management, a Registered Investment Advisor focused on emerging growth companies; and founded Mederi Therapeutics, a medical device company where he served as Chairman.
Currently Steve serves as Chairman of Oxford Square Capital (NASDAQ: OXSQ), a publicly traded business development company, and Quisk, Inc., a mobile payments platform provider now disposing of its assets. Steve earned a B.S. degree from Purdue in Industrial Management with a concentration in Computer Science, and an MBA in Finance from the Harvard Business School.